National Cancer Institute honors Berlin’s contributions, leadership
Vanderbilt’s Jordan Berlin, MD, is a 2022 recipient of the National Cancer Institute Director’s Award.
Related Articles
Home – The Robert A. Winn Diversity in Clinical Trials Award Program
The Robert A. Winn Diversity In Clinical Trials Award Program Increasing diversity in clinical trials to reduce health disparities and improve health outcomes in all…
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
AbstractArtificial intelligence (AI) in oncology is advancing beyond algorithm development to integration into clinical practice. This review describes the current state of the field, with…
New York Female Asian Nonsmoker Screening Study | NYU Langone Health
NYU Langone’s New York Female Asian Nonsmoker Screening Study (FANSS) explores early detection of lung cancer in this high-risk population.
Using the National Cancer Plan to Drive Innovation in Cancer Research
Summary:. The NCI director presents her vision of the National Cancer Plan as an integrated framework that can help drive innovation in cancer research to…
AstraZeneca’s Imfinzi Clinches Late-Stage Victory in Aggressive Lung Cancer
Following disappointing Phase III results in less aggressive non-small cell lung cancer, AstraZeneca on Friday announced that Imfinzi improved progression-free and overall survival in patients…
2024 AACR Runners for Research 5K Run/WalkI’m fundraising for American Association for Cancer Research and cancer research!
2024 AACR Runners for Research 5K Run/WalkEvent landing page for 2024 AACR Runners for Research 5K Run/Walk
National Minority Quality Forum Announces 2024 “40 Under 40 Leaders in Minority Health” Award Recipients – National Minority Quality Forum
WASHINGTON, D.C. (March 18, 2024) —Today, National Minority Quality Forum (NMQF) announced its 40 Under 40 Leaders in Minority Health for 2024 that will receive…
A Proclamation on National Lung Cancer Awareness Month, 2023 | The White House
This year, nearly 250,000 Americans will be diagnosed with lung cancer, the leading cause of cancer death in the United States. During National…
A Proclamation on National Lung Cancer Awareness Month, 2023 | The White House
This year, nearly 250,000 Americans will be diagnosed with lung cancer, the leading cause of cancer death in the United States. During National…
Engineering Multimodal Immunotherapies against Small-Cell Neuroendocrine Tumors | The Mark Foundation for Cancer Research
Small-cell neuroendocrine tumors (SCNTs) represent an aggressive group of difficult-to-treat tumors with shared characteristics that pose significant challenges in patient care.